Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.22
+0.05 (0.97%)
Jan 22, 2025, 11:35 AM EST - Market open
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 56 employees as of December 31, 2023.
Employees
56
Change
n/a
Growth
n/a
Revenue / Employee
$47,268
Profits / Employee
-$1,030,125
Market Cap
198.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
OBIO News
- 2 months ago - Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 5 months ago - Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 8 months ago - Orchestra BioMed to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 9 months ago - Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 9 months ago - Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents - GlobeNewsWire
- 10 months ago - Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update - GlobeNewsWire
- 10 months ago - Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors - GlobeNewsWire